Meso Numismatics

Regenerative Medical Technology Group, formerly known as Meso Numismatics, is a biotechnology company specializing in the field of regenerative medicine and cellular therapies. The company operates primarily through its wholly-owned subsidiary, Global Stem Cells Group, which provides a comprehensive suite of products including mesenchymal stem cells, exosomes, and peptides under the CELLGENIC brand. In addition to product distribution, the company manages an international network of clinics and the International Society for Stem Cell Applications (ISSCA), which offers specialized training and certification for physicians. Historically focused on the numismatics industry, the company completed a strategic rebranding and name change in 2024 to reflect its full transition into the biotechnology sector. Its business model combines the sale of regenerative medical equipment and biologics with clinical services and professional education across more than 20 countries.